Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
46.08
+0.45 (0.99%)
At close: Mar 20, 2026, 4:00 PM EDT
45.19
-0.89 (-1.93%)
After-hours: Mar 20, 2026, 4:55 PM EDT
KNSA Market Cap
KNSA has a market cap or net worth of $3.53 billion as of March 20, 2026. Its market cap has increased by 128.25% in one year.
Market Cap
3.53B
Enterprise Value
3.12B
1-Year Change
128.25%
Ranking
Category
Stock Price
$46.08
Market Cap Chart
Since May 24, 2018, KNSA's market cap has increased from $943.14M to $3.53B, an increase of 273.94%. That is a compound annual growth rate of 18.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 3.53B | 12.80% |
| Dec 31, 2025 | 3.13B | 118.93% |
| Dec 31, 2024 | 1.43B | 15.76% |
| Dec 29, 2023 | 1.23B | 18.45% |
| Dec 30, 2022 | 1.04B | 28.46% |
| Dec 31, 2021 | 810.82M | -32.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hims & Hers Health | 5.02B |
| Lantheus Holdings | 4.94B |
| Alkermes | 4.69B |
| Amneal Pharmaceuticals | 3.72B |
| Liquidia | 3.21B |
| Prestige Consumer Healthcare | 2.89B |
| Supernus Pharmaceuticals | 2.74B |
| BioCryst Pharmaceuticals | 2.43B |